中国伤残医学
中國傷殘醫學
중국상잔의학
CHINESE JOURNAL OF TRAUMA AND DISABILITY MEDICINE
2014年
15期
12-14
,共3页
脑梗死%丹参酮ⅡA磺酸钠%临床疗效
腦梗死%丹參酮ⅡA磺痠鈉%臨床療效
뇌경사%단삼동ⅡA광산납%림상료효
Cerebral infarction%Tanshinone injection%Clinical efficacy
目的：评价丹参酮ⅡA磺酸钠治疗急性脑梗死临床疗效。方法：选择我院2009年7月～2012年10月收治的急性脑梗死患者。80例为对照组，采用常规方法治疗。另选择同期收治的80例急性脑梗死患者为观察组，在常规治疗的同时加用丹参酮ⅡA磺酸钠治疗。对比2组的临床疗效及治疗前后神经功能缺损和日常生活能力的变化情况。结果：经治疗后，其中观察组总有效率为93．75％，对照组为77．50％，2组对照差异有统计学意义（P＜O．01）。而治疗后2组神经功能缺损评分以及日常生活能力评分比较观察组均优于对照组，差异有统计学意义（P＜0．01）。结论：将丹参酮ⅡA磺酸钠用于急性脑梗死临床治疗，能取得显著疗效，值得临床推广应用。
目的：評價丹參酮ⅡA磺痠鈉治療急性腦梗死臨床療效。方法：選擇我院2009年7月～2012年10月收治的急性腦梗死患者。80例為對照組，採用常規方法治療。另選擇同期收治的80例急性腦梗死患者為觀察組，在常規治療的同時加用丹參酮ⅡA磺痠鈉治療。對比2組的臨床療效及治療前後神經功能缺損和日常生活能力的變化情況。結果：經治療後，其中觀察組總有效率為93．75％，對照組為77．50％，2組對照差異有統計學意義（P＜O．01）。而治療後2組神經功能缺損評分以及日常生活能力評分比較觀察組均優于對照組，差異有統計學意義（P＜0．01）。結論：將丹參酮ⅡA磺痠鈉用于急性腦梗死臨床治療，能取得顯著療效，值得臨床推廣應用。
목적：평개단삼동ⅡA광산납치료급성뇌경사림상료효。방법：선택아원2009년7월～2012년10월수치적급성뇌경사환자。80례위대조조，채용상규방법치료。령선택동기수치적80례급성뇌경사환자위관찰조，재상규치료적동시가용단삼동ⅡA광산납치료。대비2조적림상료효급치료전후신경공능결손화일상생활능력적변화정황。결과：경치료후，기중관찰조총유효솔위93．75％，대조조위77．50％，2조대조차이유통계학의의（P＜O．01）。이치료후2조신경공능결손평분이급일상생활능력평분비교관찰조균우우대조조，차이유통계학의의（P＜0．01）。결론：장단삼동ⅡA광산납용우급성뇌경사림상치료，능취득현저료효，치득림상추엄응용。
Objective:To evaluate clinical efficacy of Tanshinone injection in the treatment of acute cerebral infarction .Methods:To-tally 8O cases of acute cerebral infarction admitted to hospital from July 2009 to September 2012 as the control group using conventional methods for treatment.Another selected the same period 8O cases were admitted with acute cerebral infarction 80 cases as the observation group.while in the conventional treatment plus Tanshinone injection .Clinical efficacy before and after treatment ,neurological deficits and activities of daily living ,changes in the two groups were compared .Results:After treatment , the total effective rate was 93 .75%in obser-vation group,77.50%in the control group,the difference was statistically significant (P<0.01).After treatment,the nerve function defect score decreased significantly than before ,while the observation group decreased more significantly than the control group (P<0.01);Ac-tivities of daily living scores after treatment compared with before the treatmen were obviously increase , the observation group was better than the control group(P<0.01).After treatment,the difference was statistically significant .Conclusion:The clinical efficacy of Tanshi-none injection in treatment of acute cerebral infarction can significantly improve the neurological dysfunction in patients and improve the daily living skills ,So that the patient's quality of life were improved .
